Last Updated : December 22, 2003
Details
FilesGeneric Name:
Gefitinib
Project Status:
Complete
Therapeutic Area:
Cancer, Lung , non-small cell
Manufacturer:
AstraZeneca
Brand Name:
Iressa
Project Line:
Reimbursement Review
Project Number:
SR0003-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Cancer, Lung , non-small cell
Recommendation Type:
Do not list
Final Recommendation:
Recommendation:
Not to list.
Files
Last Updated : December 22, 2003